Shuttle Pharmaceuticals Holdings (SHPH) Other Working Capital Changes (2021 - 2026)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Other Working Capital Changes came in at -$904.0 in Q1 2026, down 332.54% year-on-year from $388.76 in Q1 2025, and little changed quarter-over-quarter from -$904.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Other Working Capital Changes history runs 6 years deep, the most recent figure standing at -$904.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 332.54% year-over-year to -$904.0 in Q1 2026; TTM through Mar 2026 was -$3154.0, a 710.8% decrease from a year earlier, with the FY2025 full-year figure at -$2459.0, down 959.79% from the prior year.
- Other Working Capital Changes steadied at -$904.0 in Q1 2026 per SHPH's latest filing, from -$904.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $9388.0 in Q3 2023 and bottomed at -$1894.0 in Q1 2023.
- The 3-year median for Other Working Capital Changes is $156017.0 (2025), against an average of $455774.7.
- Biggest YoY gain for Other Working Capital Changes was 671.78% in 2026; the steepest drop was 671.78% in 2026.
- Year by year, Other Working Capital Changes stood at -$1707.0 in 2022, then soared by 489.16% to $6643.0 in 2023, then slumped by 103.19% to -$212.0 in 2024, then slumped by 326.42% to -$904.0 in 2025, then changed by 0.0% to -$904.0 in 2026.
- Per Business Quant, the three latest SHPH Other Working Capital Changes figures stand at -$904.0 (Q1 2026), -$904.0 (Q4 2025), and -$905.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -904.00 |
| Mar 31, 2026 | -904.00 |
| Mar 31, 2026 | -904.00 |
| Dec 31, 2025 | -904.00 |
| Dec 31, 2025 | -904.00 |
| Dec 31, 2025 | -904.00 |
| Sep 30, 2025 | -905.00 |
| Sep 30, 2025 | -905.00 |
| Sep 30, 2025 | -905.00 |
| Jun 30, 2025 | -441.00 |
| Jun 30, 2025 | -441.00 |
| Jun 30, 2025 | -441.00 |
| Mar 31, 2025 | -209.00 |
| Mar 31, 2025 | -209.00 |
| Mar 31, 2025 | -209.00 |
| Dec 31, 2024 | -212.00 |
| Dec 31, 2024 | -212.00 |
| Dec 31, 2024 | -212.00 |
| Sep 30, 2024 | -205.00 |
| Sep 30, 2024 | -205.00 |